Global Health Ventures Inc. (OTC Bulletin Board: GHLV) has been working on the development of a new anti-stress medication “Relax-B” using its sublingual technology. The company’s lead therapeutic product “X-Excite” is already making its way through the clinical trials.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
The Company started the development of a second drug “Relax-B” designed to cause relaxation of muscles leading to stress relief. The new product uses an already FDA approved drug with a special formulation at a low dosage which causes it to rapidly reach the bloodstream.
Global Health Ventures is a specialty pharma focused on the life style products. The company has a new proprietary platform technology for drug delivery via the sublingual (under the tongue) route.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
